Results 181 to 190 of about 2,075,366 (204)

12 Prevalence of transthyretin amyloid cardiomyopathy (aTTR-CM) in undifferentiated HFpEF

Oral abstract presentations 2, 2022
L Healy, G Giblin, D O’Sullivan, E Kavanagh, E Howley, C Tracey, J O’Neill, E Joyce, M O’Connell, A McDaid, A Clarke, A Gray, N Mahon   +12 more
openaire   +1 more source

Retrospective Evaluation Of Suspected Vs. Confirmed Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Cases

Journal of Cardiac Failure, 2022
Taylor E. Akers, Kevin Lynch
openaire   +1 more source

Clinical characteristics of patients with hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) in Sarawak

International Journal of Cardiology, 2021
L.S. Chen, Y.Y. Oon, B.K. Chung, L.K. Thien, H.B. Chow, I.X. Pang, H.S. Ling, D.B. Chandan, C.T. Tan, K.T. Koh, A. Said, Y.L. Cham, A.Y.Y. Alan, T.K. Ong   +13 more
openaire   +1 more source

Progress in ATTR-CM: A Detailed Exploration of Pathophysiology, Diagnostics, and Treatment Approaches

Transthyretin amyloid cardiomyopathy (ATTR-CM) represents a progressive and underrecognized condition driven by the deposition of misfolded transthyretin (TTR) amyloid fibrils in the heart. Through this review, we aim to explore the complexities of ATTR-CM, including its classification into wild-type (wtATTR), predominantly affecting older males, and ...
NAVEEN V, FELIC S, ABISHEK P
openaire   +1 more source

Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Cardiac Outcomes of SGLT2i on wt-ATTR-CM.

American Journal of Cardiology
Stefano H. Byer, Aravinthasamy Sivamurugan, U. Grewal, Michael G. Fradley, Paari Dominic   +4 more
semanticscholar   +1 more source

Acoramidis improves survival and functional status in ATTR-CM

Medicom Conference Report ESC 2023, 2023
openaire   +1 more source

A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?

Journal of Cardiac Failure
Mathew S. Maurer
semanticscholar   +1 more source

Should ATTR-CM be added to the differential diagnosis of patients with HF?

Medicom Conference Report HFA 2022, 2022
Rocío Ruiz Hueso, Robert van den Heuvel
openaire   +1 more source

Transthyretin Amyloidosis (ATTR-CM)

Cardiovascular Research Prove Journal
openaire   +2 more sources

Vyndaqel Capsules Special Investigation (ATTR-CM)

Case Medical Research, 2019
openaire   +1 more source